Lightnews — Scholar-powered news

Reposted by Vivek Subbiah, MD

OncoDaily

@oncodaily.bsky.social

AI-Driven Screening Opens New Era in Drug Discovery - Vivek Subbiah

@viveksubbiah.bsky.social

oncodaily.com/voices/vivek...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews

Vivek Subbiah: AI-Driven Screening Opens New Era in Drug Discovery - OncoDaily

Vivek Subbiah: AI-Driven Screening Opens New Era in Drug Discovery / Bowen Gao, cancer, Chuangye Yan, Haichuan Tan, Hongyi Cai, Jiaxin Tan, Jiekang Tian,

oncodaily.com

January 26, 2026 at 10:14 PM

Reposted by Vivek Subbiah, MD

OncoDaily

@oncodaily.bsky.social

Rethinking Cancer of Unknown Primary in Precision Oncology Era - Vivek Subbiah

@viveksubbiah.bsky.social

oncodaily.com/voices/vivek...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews

Vivek Subbiah: Rethinking Cancer of Unknown Primary in Precision Oncology Era - OncoDaily

Vivek Subbiah: Rethinking Cancer of Unknown Primary in Precision Oncology Era / cancer, F. Anthony Greco, Journal of Clinical Oncology, OncoDaily, Oncology,

oncodaily.com

January 14, 2026 at 9:00 PM

Reposted by Vivek Subbiah, MD

American Society of Clinical Oncology

@ascocancer.bsky.social

🎙️ @hoperugo.bsky.social of @cityofhope.bsky.social & @viveksubbiah.bsky.social of Sarah Cannon Research Institute discuss innovative trial designs, treatment strategies, and key insights on the future of rare cancer research on the ASCO Education #BytheBook Podcast. url-shortener.me/820P
#ASCOEdBook

January 16, 2026 at 4:15 PM

Reposted by Vivek Subbiah, MD

OncoDaily

@oncodaily.bsky.social

Great Debates Congratulates Yelena Janjigian and Vivek Subbiah on Being Named Among the Most Influential People in Oncology in 2025

@viveksubbiah.bsky.social

oncodaily.com/voices/great...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews

Great Debates Congratulates Yelena Janjigian and Vivek Subbiah on Being Named Among the Most Influential People in Oncology in 2025 - OncoDaily

Great Debates Congratulates Yelena Janjigian and Vivek Subbiah on Being Named Among the Most Influential People in Oncology in 2025 / cancer, Great Debates,

oncodaily.com

January 18, 2026 at 2:00 AM

Reposted by Vivek Subbiah, MD

OncoDaily

@oncodaily.bsky.social

The 100 Most Influential People in Oncology in 2025

oncodaily.com/100/100-most...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #The100MostInfluentialPeopleinOncology

December 20, 2025 at 8:00 PM

Reposted by Vivek Subbiah, MD

OncoDaily

@oncodaily.bsky.social

Vivek Subbiah Shares a Study on Why Cancer Can Return Years Later and How to Stop It

@viveksubbiah.bsky.social

oncodaily.com/voices/vivek...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews

Vivek Subbiah Shares a Study on Why Cancer Can Return Years Later and How to Stop It - OncoDaily

Vivek Subbiah Shares a Study on Why Cancer Can Return Years Later and How to Stop It / cancer, OncoDaily, Oncology, Vivek Subbiah

oncodaily.com

January 11, 2026 at 1:01 AM

Reposted by Vivek Subbiah, MD

OncoDaily

@oncodaily.bsky.social

oncodaily.com

January 12, 2026 at 9:01 PM

Vivek Subbiah, MD

@viveksubbiah.bsky.social

Why cancer can come back years later — and how to stop it www.nature.com/articles/d41...

Why cancer can come back years later — and how to stop it

Researchers are targeting dormant tumour cells that might explain why some cancers reappear long after successful treatment.

www.nature.com

January 8, 2026 at 3:14 AM

Reposted by Vivek Subbiah, MD

OncoDaily

@oncodaily.bsky.social

10 Must-Read Posts in GI Oncology This Week

@viveksubbiah.bsky.social

oncodaily.com/oncolibrary/...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #GIOnc

10 Must-Read Posts in GI Oncology This Week - OncoDaily

10 Must-Read Posts in GI Oncology This Week / cancer, cancer care, Cancer research, cancer treatment, clinical trials, Colorectal Cancer (CRC),

oncodaily.com

December 15, 2025 at 6:34 PM

Vivek Subbiah, MD

@viveksubbiah.bsky.social

Science in 2026: the events to watch for in the coming year www.nature.com/articles/d41...

Science in 2026: the events to watch for in the coming year

The rise of AI scientists, missions to explore the moons of Earth and Mars and a massive ocean-floor drill are among the developments set to shape research in 2026.

www.nature.com

December 20, 2025 at 4:41 AM

Reposted by Vivek Subbiah, MD

OncoDaily

@oncodaily.bsky.social

Tissue-Agnostic Cancer Therapies Promise to Revolutionize Oncology by Targeting Molecular Drivers - Vivek Subbiah

@viveksubbiah.bsky.social

oncodaily.com/voices/vivek...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews

Vivek Subbiah: Tissue-Agnostic Cancer Therapies Promise to Revolutionize Oncology by Targeting Molecular Drivers - OncoDaily

Vivek Subbiah: Tissue-Agnostic Cancer Therapies Promise to Revolutionize Oncology by Targeting Molecular Drivers / cancer, cancer treatment, Headlines,

oncodaily.com

November 24, 2025 at 12:02 AM

Reposted by Vivek Subbiah, MD

OncoDaily

@oncodaily.bsky.social

Thrilled to Share My Editorial on the ROME Trial - Vivek Subbiah

@viveksubbiah.bsky.social

oncodaily.com/voices/vivek...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews

Vivek Subbiah: Thrilled to Share My Editorial on the ROME Trial - OncoDaily

Vivek Subbiah: Thrilled to Share My Editorial on the ROME Trial / Agnese Fabbri, Alberto Zambelli, Andrea Botticelli, Andrea DeCensi, Annamaria Pessino, Bruna

oncodaily.com

November 13, 2025 at 9:44 PM

Reposted by Vivek Subbiah, MD

OncoDaily

@oncodaily.bsky.social

ONE of the Most Impactful Meetings in Rare Cancer Research - Vivek Subbiah

@viveksubbiah.bsky.social

oncodaily.com/voices/vivek...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews

Vivek Subbiah: ONE of the Most Impactful Meetings in Rare Cancer Research - OncoDaily

Vivek Subbiah: ONE of the Most Impactful Meetings in Rare Cancer Research / cancer, OncoDaily, Oncology, Razelle Kurzrock, Target Cancer Foundation, Think

oncodaily.com

November 2, 2025 at 9:42 PM

Reposted by Vivek Subbiah, MD

Hannah R. Abrams

@hannahrabrams.bsky.social

2. Need structured approaches for how to evaluate even when an ultra-specific histology driven approach isn't feasible, as @viveksubbiah.bsky.social outlines for rare cancers here: ascopubs.org/doi/10.1200/...

Imperative of Comprehensive Molecular Profiling as Standard of Care for Patients With Rare Cancers | JCO Oncology Practice

ascopubs.org

October 28, 2025 at 1:04 AM

Reposted by Vivek Subbiah, MD

AACR Journals

@aacrjournals.bsky.social

Read the Cancer Discovery Piece: Rethinking Cancer Drug Development through Tumor-Agnostic Precision Medicine by @viveksubbiah.bsky.social doi.org/10.1158/2159...

I-Mei @i-mei.bsky.social · Oct 20

Great #ESMO25 talk by @viveksubbiah.bsky.social on targeting molecular drivers of cancer in a tissue-agnostic manner: for more of his thoughts, check out his @aacrjournals.bsky.social Cancer Discovery piece (online as of October 17) here:

October 20, 2025 at 1:37 PM

Reposted by Vivek Subbiah, MD

OncoDaily

@oncodaily.bsky.social

ESMO 2025 - Catalyzing Novel Collaborations for Global Impact in Oncology - Vivek Subbiah

@viveksubbiah.bsky.social @myesmo.bsky.social

oncodaily.com/voices/esmo-...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #ESMO25

Vivek Subbiah: ESMO 2025 - Catalyzing Novel Collaborations for Global Impact in Oncology - OncoDaily

Vivek Subbiah: ESMO 2025 - Catalyzing Novel Collaborations for Global Impact in Oncology / cancer, ESMO, ESMO 2025, OncoDaily, Oncology, Vivek Subbiah

oncodaily.com

October 11, 2025 at 6:58 PM

Reposted by Vivek Subbiah, MD

OncoDaily

@oncodaily.bsky.social

Honored to Present at ESMO Annual Meeting Young Oncologists Clinical Case Discussions - Vivek Subbiah

@viveksubbiah.bsky.social @myesmo.bsky.social

oncodaily.com/voices/vivek...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews

Vivek Subbiah: Honored to Present at ESMO Annual Meeting Young Oncologists Clinical Case Discussions - OncoDaily

Vivek Subbiah: Honored to Present at ESMO Annual Meeting Young Oncologists Clinical Case Discussions / cancer, ESMO Annual Meeting, ESMO25, Maximilian Kloft,

oncodaily.com

October 12, 2025 at 10:28 PM

Reposted by Vivek Subbiah, MD

OncoDaily

@oncodaily.bsky.social

Precision Oncology and Modernizing Evidence Standards - Vivek Subbiah

@viveksubbiah.bsky.social

oncodaily.com/voices/vivek...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews

Vivek Subbiah: Precision Oncology and Modernizing Evidence Standards - OncoDaily

Vivek Subbiah: Precision Oncology and Modernizing Evidence Standards / cancer, OncoDaily, Oncology, Razelle Kurzrock, Vivek Subbiah

oncodaily.com

October 13, 2025 at 7:03 PM

Reposted by Vivek Subbiah, MD

OncoDaily

@oncodaily.bsky.social

ESMO Presidential Dinner is Kicking Off in Berlin - Vivek Subbiah

@viveksubbiah.bsky.social @myesmo.bsky.social

oncodaily.com/voices/vivek...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #ESMO #ESMO25 #ESMO2025

Vivek Subbiah: ESMO Presidential Dinner is Kicking Off in Berlin - OncoDaily

Vivek Subbiah: ESMO Presidential Dinner is Kicking Off in Berlin / cancer, ESMO, ESMO 2025, ESMO 2025 Congress, ESMO Presidential Dinner, ESMO2025, ESMO25,

oncodaily.com

October 20, 2025 at 10:02 PM

Reposted by Vivek Subbiah, MD

OncoDaily

@oncodaily.bsky.social

Rethinking Cancer Drug Development Through Tumor-Agnostic Precision Medicine - Vivek Subbiah

@viveksubbiah.bsky.social

oncodaily.com/voices/vivek...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #ESMO #ESMO25 #ESMO2025

Vivek Subbiah: Rethinking Cancer Drug Development Through Tumor-Agnostic Precision Medicine - OncoDaily

Vivek Subbiah: Rethinking Cancer Drug Development Through Tumor-Agnostic Precision Medicine / cancer, ESMO, ESMO 2025, ESMO 2025 Congress, ESMO2025, ESMO25,

oncodaily.com

October 18, 2025 at 2:48 PM

Reposted by Vivek Subbiah, MD

I-Mei

@i-mei.bsky.social

Great #ESMO25 talk by @viveksubbiah.bsky.social on targeting molecular drivers of cancer in a tissue-agnostic manner: for more of his thoughts, check out his @aacrjournals.bsky.social Cancer Discovery piece (online as of October 17) here:

October 20, 2025 at 6:37 AM

Reposted by Vivek Subbiah, MD

OncoDaily

@oncodaily.bsky.social

Smarter Trial Designs: How Project Optimus is Changing Early-Phase Cancer Research - Vivek Subbiah

@viveksubbiah.bsky.social

oncodaily.com/voices/vivek...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews

Vivek Subbiah: Smarter Trial Designs - How Project Optimus is Changing Early-Phase Cancer Research - OncoDaily

Vivek Subbiah: Smarter Trial Designs - How Project Optimus is Changing Early-Phase Cancer Research / American Society of Clinical Oncology, ASCO, cancer,

oncodaily.com

October 7, 2025 at 9:31 PM

Reposted by Vivek Subbiah, MD

Jia (Jenny) Liu MD PhD

@jiajennyliu.bsky.social

D-7 until #ESMO25! 👋🇩🇪

Excited to be part of first ever tumor-agnostic scientific track with @viveksubbiah.bsky.social @JulianaRBeale #NiamhColeman

Don’t miss these educational sessions! ⬇️ @myesmo.bsky.social